Formulation and Evaluation of Chronomodulated Drug Delivery of Montelukast Sodium-Juniper Publishers

Juniper Publishers-Open Access Journal of Pharmacy & Pharmaceutical Sciences


Authored by Madhuri Asiniparthi

An oral press coated tablet containing Montelukast sodium was formulated with an outer barrier layer of different compositions of hydrophobic polymer eythyl cellulose and hydrophilic polymer hydroxyl propyl methyl cellulose. This press coated tablet was prepared by using direct compression and wet granulation methods in order to achieve the predetermined lag time.

Comments

Post a Comment

Popular posts from this blog

Etilefrine Could Improve Response to Standard Medical Therapy in Chronic Hepatitis C Egyptian Patients with Cirrhotic Refractory Ascites: A Randomized Pilot Study-Juniper Publishers

Image
JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF PHARMACY & PHARMACEUTICAL SCIENCES Introduction Ascites is the most common of the three major complications of cirrhosis; the other complications are hepatic encephalopathy and variceal hemorrhage [ 1 ]. Approximately 50% of patients with "compensated" cirrhosis develop ascites during 10 years of observation [ 1 ]. Ascites is the most common complication of cirrhosis that leads to hospital admission [ 2 ]. Development of fluid retention in the setting of cirrhosis is an important landmark in the natural history of chronic liver disease: approximately 15% of patients with ascites succumb in 1 year and 44% succumb in 5 years [ 3 ]. Many patients are referred for liver transplantation after development of ascites. Refractory ascites develops in approximately 5-10% of all cases of cirrhosis- related ascites and carries a high mortality rate [ 4 ]. The available therapies for patients with refractory ascites are re...
Read more